Fimbrion Therapeautics aims to discover, develop, and commercialize antimicrobial-sparing, first-in-class antivirulence drugs for the prevention and treatment of infectious diseases caused by bacteria, including anbitiotic-resistant strains.
Company (Alive / Active)
Phone:
20 S. Sarah Street
Saint Louis, 63108
Missouri, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Mannose-derived antagonists of fimh useful for treating disease | Mar 23, 2017 | Aug 11, 2020 | Patent |
C-glycoside compounds useful for treating disease | Mar 11, 2017 | Application |